Metaplastic Carcinoma of Breast: Case Series with Cytohistological Correlation

Abstract

Metaplastic carcinoma of breast (MCB) is a rare breast malignancy. It is important to differentiate metaplastic carcinoma from malignant phyllodes and primary breast sarcomas because of their differing biological behavior and prognosis. We report four cases of MCB diagnosed over the past 15 years. Retrospective review of patient records in a tertiary care setting to retrieve cases diagnosed as MCB. Patient records of the past 15 years (2002–2015) were retrieved. Four histopathologically diagnosed cases of metaplastic carcinoma out of a total of 880 archived cases of breast carcinoma were studied along with their cytopathology. Immunohistochemistry was performed on sections. MCB comprised 0.45% of all breast malignancies. The four cases of MCB included MCB with chondroid metaplasia, spindle cell carcinoma, adenosquamous carcinoma, and carcinosarcoma. All the tumors were invariably triple negative (estrogen receptor, progesterone receptor, and Her2/Neu negative) and expression of other epithelial and mesenchymal markers was variable. MCB is a rare breast malignancy. Differential diagnosis is related to the presence of heterologous elements and degree of atypia seen in the lesion. It is important to be aware of this entity as it carries a poor prognosis.

Keywords

Breast - carcinoma - fine-needle aspiration cytology - histopathology - immunohistochemistry - metaplastic

• References

• 1 Huvos AG, Lucas Jr. JC, Foote Jr. FW. Metaplastic breast carcinoma. Rare form of mammary cancer. N Y State J Med 1973; 73: 1078-82
• 2 Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, Eusebi V. et al. Invasive breast carcinoma. In Tavassoli FA, Devilee P. editors WHO Classification of Tumors of the Breast. Lyon, France: IARC; 2003: 37-40
• 3 Tavassoli FA. Classification of metaplastic carcinomas of the breast. Pathol Annu 1992; 27 Pt 2 89-119
• 4 Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 2006; 45: 188-95
• 5 Rossi L, Paglicci C, Caprio G, Barberi S, Ranieri E, Zancla S. et al. Matrix-producing carcinoma of the breast: A case report. Case Rep Oncol 2013; 6: 245-9
• 6 Rungta S, Kleer CG. Metaplastic carcinomas of the breast: Diagnostic challenges and new translational insights. Arch Pathol Lab Med 2012; 136: 896-900
• 7 Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol 1990; 21: 1142-50
• 8 Graziano L, Filho GP, Bitencourt AG, Soto DB, Hiro A, Nunes CC. et al. Metaplastic squamous cell carcinoma of the breast: A case report and literature review. Rev Assoc Med Bras (1992) 2016; 62: 618-21
• 9 Joshi D, Singh P, Zonunfawni Y, Gangane N. Metaplastic carcinoma of the breast: Cytological diagnosis and diagnostic pitfalls. Acta Cytol 2011; 55: 313-8
• 10 Papazian M, Kalantzis I, Galanopoulos G, Mani I, Tzaida O, Iacovidou I. et al. Malignant myoepithelioma of the breast: A case report and review of the literature. Mol Clin Oncol 2016; 4: 723-7
• 11 Niu Y, Liao X, Li X, Zhao L. Breast carcinoma with osteoclastic giant cells: Case report and review of the literature. Int J Clin Exp Pathol 2014; 7: 1788-91
• 12 Neelam S, Sanjay G. Invasive duct carcinoma of the breast with multinucleated osteoclast-like giant cells: A rare case diagnosed on fine needle aspiration cytology. Breast J 2012; 18: 596-7
• 13 Adem C, Reynolds C, Ingle JN, Nascimento AG. Primary breast sarcoma: Clinicopathologic series from the mayo clinic and review of the literature. Br J Cancer 2004; 91: 237-41
• 14 Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. et al. Metaplastic carcinoma of the breast: A clinicopathological review. J Clin Pathol 2006; 59: 1079-83
• 15 Altaf FJ, Mokhtar GA, Emam E, Bokhary RY, Mahfouz NB, Al Amoudi S. et al. Metaplastic carcinoma of the breast: An immunohistochemical study. Diagn Pathol 2014; 9: 139